In arthritis, activated T cells regulate bone loss and joint destruction by regulating the equilibrium between the receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG). This evidence concerns the gene TNFRSF11B and arthritic joint disease.